首页> 外文期刊>Journal of international management >Multidrug-Resistant Candida auris Fungemia in Critical Care Units: Experience from a Tertiary Care Hospital in India
【24h】

Multidrug-Resistant Candida auris Fungemia in Critical Care Units: Experience from a Tertiary Care Hospital in India

机译:在关键护理单位中的多药抗性念珠菌毒性尿血症:印度高等护理医院的经验

获取原文
获取原文并翻译 | 示例
           

摘要

Candida auris, a recently identified multiresistant Candida species, was first reported in Japan in 2009. It is different from other pathogenic yeast species because of its propensity to cause outbreaks and transmits between patients within health care settings. The invasive infections caused by C. auris are associated with high mortality rates, approaching 70% particularly in intensive care unit patients. Conventional biochemical methods are inaccurate in identifying this species of Candida. Although C. auris is frequently reported as multi-, extended-, or pan drug resistant to antifungal drugs, there is a wide variability in the susceptibility among reports worldwide. In this study we report a case series of five hospitalized patients with multidrug-resistant candidemia caused by C. auris in a tertiary hospital in India. Our finding suggests that correct identification followed by therapeutic intervention is necessary for favorable outcome in patients with C. auris fungemia.
机译:2009年首次在日本报道了最近发现的多人念珠菌物种的念珠菌Auris。它与其他致病酵母物种不同,因为它具有促进疾病和医疗保健环境内的患者之间的爆发和传递。 由C.Auris引起的侵袭性感染与高死亡率相关,接近70%,特别是在重症监护室内患者。 鉴定这种念珠菌的常规生化方法是不准确的。 虽然C.Auris经常被报告为对抗真菌药物的多重,延长或泛毒性耐药性,但全球报告中的易感性有很大的变化。 在这项研究中,我们向印度一家高级医院造成的C. Auris引起的C. auris引起的五种住院患者案例系列五次住院患者。 我们的发现表明,对于C.Auris FunGemia患者有利的结果,需要正确的识别,然后是治疗干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号